A Study of Seltorexant in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 14, 2020

Primary Completion Date

December 20, 2020

Study Completion Date

December 30, 2020

Conditions

Healthy

Interventions

DRUG

Seltorexant

Seltorexant will be administered orally as per assigned treatment sequence.

Trial Locations (1)

PRA Health Sciences, Salt Lake City

All Listed Sponsors

lead

Janssen Research & Development, LLC

INDUSTRY

NCT04553042 - A Study of Seltorexant in Healthy Participants | Biotech Hunter | Biotech Hunter